{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:07:34Z","timestamp":1774922854042,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10585-020-10047-x","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T16:06:48Z","timestamp":1592410008000},"page":"565-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Phase II trial of high dose stereotactic body radiation therapy for lymph node oligometastases"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-6284","authenticated-orcid":false,"given":"Ciro","family":"Franzese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Comito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Tripoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierina","family":"Navarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Badalamenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"D\u2019agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Loi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Mancosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Reggiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tomatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"10047_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8\u201310","journal-title":"J Clin Oncol"},{"issue":"2","key":"10047_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/jjco\/hyp167","volume":"40","author":"Y Niibe","year":"2010","unstructured":"Niibe Y, Hayakawa K (2010) Oligometastases and oligo-recurrence: the new era of cancer therapy. Jpn J Clin Oncol 40(2):107\u2013111. https:\/\/doi.org\/10.1093\/jjco\/hyp167","journal-title":"Jpn J Clin Oncol"},{"key":"10047_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(11)70142-3","author":"J Ruiterkamp","year":"2011","unstructured":"Ruiterkamp J, Ernst MF (2011) The role of surgery in metastatic breast cancer. Eur J Cancer. https:\/\/doi.org\/10.1016\/S0959-8049(11)70142-3","journal-title":"Eur J Cancer"},{"key":"10047_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4653","author":"R Rai","year":"2004","unstructured":"Rai R, Rai S (2004) Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg. https:\/\/doi.org\/10.1002\/bjs.4653","journal-title":"Br J Surg"},{"issue":"5","key":"10047_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/01.sla.0000160703.75808.7d","volume":"241","author":"TM Pawlik","year":"2005","unstructured":"Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241(5):715\u2013724. https:\/\/doi.org\/10.1097\/01.sla.0000160703.75808.7d","journal-title":"Ann Surg"},{"issue":"9","key":"10047_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1590\/S1807-59322010000900010","volume":"65","author":"RAS Sardenberg","year":"2010","unstructured":"Sardenberg RAS, de Figueiredo LP, Haddad FJ, Gross JL, Younes RN (2010) Pulmonary metastasectomy from soft tissue sarcomas. Clinics 65(9):871\u2013876. https:\/\/doi.org\/10.1590\/S1807-59322010000900010","journal-title":"Clinics"},{"issue":"11","key":"10047_CR7","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1200\/JCO.2012.45.9651","volume":"31","author":"KS Corbin","year":"2013","unstructured":"Corbin KS, Hellman S, Weichselbaum RR (2013) Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol 31(11):1384\u20131390. https:\/\/doi.org\/10.1200\/JCO.2012.45.9651","journal-title":"J Clin Oncol"},{"issue":"4","key":"10047_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10585-010-9325-0","volume":"27","author":"JK Kang","year":"2010","unstructured":"Kang JK, Kim MS, Kim JH et al (2010) Oligometastases confined one organ from colorectal cancer treated by SBRT. Clin Exp Metastasis 27(4):273\u2013278. https:\/\/doi.org\/10.1007\/s10585-010-9325-0","journal-title":"Clin Exp Metastasis"},{"issue":"8","key":"10047_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R et al (2016) ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 27(8):1386\u20131422. https:\/\/doi.org\/10.1093\/annonc\/mdw235","journal-title":"Ann Oncol"},{"issue":"8","key":"10047_CR10","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1634\/theoncologist.2012-0092","volume":"17","author":"F Alongi","year":"2012","unstructured":"Alongi F, Arcangeli S, Filippi AR, Ricardi U, Scorsetti M (2012) Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist 17(8):1100\u20131107. https:\/\/doi.org\/10.1634\/theoncologist.2012-0092","journal-title":"Oncologist"},{"issue":"1","key":"10047_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.critrevonc.2013.11.003","volume":"90","author":"B De Bari","year":"2014","unstructured":"De Bari B, Alongi F, Buglione M et al (2014) Salvage therapy of small volume prostate cancer nodal failures: a review of the literature. Crit Rev Oncol Hematol 90(1):24\u201335. https:\/\/doi.org\/10.1016\/j.critrevonc.2013.11.003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10047_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijrobp.2018.12.049","volume":"104","author":"D Franceschini","year":"2019","unstructured":"Franceschini D, De Rose F, Franzese C et al (2019) Predictive Factors for Response and survival in a cohort of oligometastatic patients treated with stereotactic body radiation therapy. Int J Radiat Oncol 104(1):111\u2013121. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.12.049","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"10047_CR13","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1700\/1377.15311","volume":"99","author":"P Bonomo","year":"2013","unstructured":"Bonomo P, Cipressi S, Saieva C et al (2013) Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases. Tumori 99(5):611\u2013616. https:\/\/doi.org\/10.1700\/1377.15311","journal-title":"Tumori"},{"key":"10047_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-7-204","author":"F Alongi","year":"2012","unstructured":"Alongi F, Fogliata A, Clerici E et al (2012) Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal\/pelvic lymph nodes: Report of dosimetric and early clinical results in oligometastatic patients. Radiat Oncol. https:\/\/doi.org\/10.1186\/1748-717X-7-204","journal-title":"Radiat Oncol"},{"issue":"2","key":"10047_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1700\/1283.14186","volume":"99","author":"R Corv","year":"2013","unstructured":"Corv R, Lamanna G, Vagge S et al (2013) Once-weekly stereotactic radiotherapy for patients with oligometastases: compliance and preliminary efficacy. Tumori 99(2):159\u2013163. https:\/\/doi.org\/10.1700\/1283.14186","journal-title":"Tumori"},{"issue":"3","key":"10047_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/COC.0b013e3182610878","volume":"37","author":"BA Jereczek-Fossa","year":"2014","unstructured":"Jereczek-Fossa BA, Piperno G, Ronchi S et al (2014) Linac-based stereotactic body radiotherapy for oligometastatic patients with single abdominal lymph node recurrent cancer. Am J Clin Oncol Cancer Clin Trials 37(3):227\u2013233. https:\/\/doi.org\/10.1097\/COC.0b013e3182610878","journal-title":"Am J Clin Oncol Cancer Clin Trials"},{"issue":"3","key":"10047_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ijrobp.2010.05.032","volume":"81","author":"M Bignardi","year":"2011","unstructured":"Bignardi M, Navarria P, Mancosu P et al (2011) Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases. Int J Radiat Oncol Biol Phys 81(3):831\u2013838. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.05.032","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10047_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2017.1375116","author":"C Franzese","year":"2017","unstructured":"Franzese C, Lopci E, Di Brina L et al (2017) 11C-Choline-pet guided stereotactic body radiation therapy for lymph node metastases in oligometastatic prostate cancer. Cancer Invest. https:\/\/doi.org\/10.1080\/07357907.2017.1375116","journal-title":"Cancer Invest."},{"key":"10047_CR19","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20170422","author":"C Franzese","year":"2017","unstructured":"Franzese C, Fogliata A, Comito T et al (2017) Stereotactic\/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis. Br J Radiol. https:\/\/doi.org\/10.1259\/bjr.20170422","journal-title":"Br J Radiol"},{"issue":"3","key":"10047_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.otohns.2009.12.034","volume":"142","author":"JH Kim","year":"2010","unstructured":"Kim JH, Kim MS, Yoo SY, Lim SM, Lee GH, Yi KH (2010) Stereotactic body radiotherapy for refractory cervical lymph node recurrence of nonanaplastic thyroid cancer. Otolaryngol Head Neck Surg 142(3):338\u2013343. https:\/\/doi.org\/10.1016\/j.otohns.2009.12.034","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10047_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijrobp.2008.07.020","volume":"74","author":"CW Choi","year":"2009","unstructured":"Choi CW, Cho CK, Yoo SY et al (2009) Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys 74(1):147\u2013153. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.07.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"48","key":"10047_CR22","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.3748\/wjg.15.6091","volume":"15","author":"MS Kim","year":"2009","unstructured":"Kim MS, Cho CK, Yang KM, Lee DH, Moon SM, Shin YJ (2009) Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer. World J Gastroenterol 15(48):6091\u20136095. https:\/\/doi.org\/10.3748\/wjg.15.6091","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10047_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00066-019-01523-9","volume":"196","author":"L Nicosia","year":"2020","unstructured":"Nicosia L, Franzese C, Mazzola R et al (2020) Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. Strahlentherapie und Onkol 196(3):213\u2013221. https:\/\/doi.org\/10.1007\/s00066-019-01523-9","journal-title":"Strahlentherapie und Onkol"},{"issue":"12","key":"10047_CR24","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/bjc.2017.103","volume":"116","author":"L Triggiani","year":"2017","unstructured":"Triggiani L, Alongi F, Buglione M et al (2017) Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study. Br J Cancer 116(12):1520\u20131525. https:\/\/doi.org\/10.1038\/bjc.2017.103","journal-title":"Br J Cancer"},{"key":"10047_CR25","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0309","author":"G Macchia","year":"2020","unstructured":"Macchia G, Lazzari R, Colombo N et al (2020) A Large, Multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups. Oncologist. https:\/\/doi.org\/10.1634\/theoncologist.2019-0309","journal-title":"Oncologist"},{"key":"10047_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-019-01523-9","author":"L Nicosia","year":"2019","unstructured":"Nicosia L, Franzese C, Mazzola R et al (2019) Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysisRezidivmuster nach stereotaktischer Radiotherapie beim oligometastasierten Prostatakarzinom: eine multiinstitutionelle Analyse. Strahlentherapie Onkol. https:\/\/doi.org\/10.1007\/s00066-019-01523-9","journal-title":"Strahlentherapie Onkol"},{"key":"10047_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-017-0820-1","author":"R Yeung","year":"2017","unstructured":"Yeung R, Hamm J, Liu M, Schellenberg D (2017) Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases. Radiat Oncol. https:\/\/doi.org\/10.1186\/s13014-017-0820-1","journal-title":"Radiat Oncol"},{"key":"10047_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2016.1197235","author":"C Franzese","year":"2016","unstructured":"Franzese C, Cozzi L, Franceschini D et al (2016) Role of stereotactic body radiation therapy with volumetric-modulated arcs and high-intensity photon beams for the treatment of abdomino-pelvic lymph-node metastases. Cancer Invest. https:\/\/doi.org\/10.1080\/07357907.2016.1197235","journal-title":"Cancer Invest"},{"key":"10047_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.10.024","author":"C Franzese","year":"2018","unstructured":"Franzese C, Comito T, Toska E et al (2018) Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy. Radiother Oncol. https:\/\/doi.org\/10.1016\/j.radonc.2018.10.024","journal-title":"Radiother Oncol"},{"issue":"10185","key":"10047_CR30","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393(10185):2051\u20132058. https:\/\/doi.org\/10.1016\/S0140-6736(18)32487-5","journal-title":"Lancet"},{"key":"10047_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03230-w","author":"R Mazzola","year":"2020","unstructured":"Mazzola R, Figlia V, Rigo M et al (May 2020) Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-020-03230-w","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10047_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jmrs.224","volume":"64","author":"LJ Bell","year":"2017","unstructured":"Bell LJ, Eade T, Kneebone A et al (2017) Initial experience with intra-fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment. J Med Radiat Sci 64(1):25\u201334. https:\/\/doi.org\/10.1002\/jmrs.224","journal-title":"J Med Radiat Sci"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-020-10047-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-020-10047-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-020-10047-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T14:36:05Z","timestamp":1628606165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-020-10047-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10047"],"URL":"https:\/\/doi.org\/10.1007\/s10585-020-10047-x","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}